Flow, compressive, and bioadhesive properties of various blends of poly(ethylene oxide)

Drug Development and Industrial Pharmacy

Volumn 36, Issue 1, 2010, Pages 45-55

  Kapil, Rishi ^a   Kapoor, Deepak N ^a   Dhawan, Sanju ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Bioadhesion; Compression; Flow properties; Gamma scintigraphy; Gastroretention; Poly(ethylene oxide)

Indexed keywords

AEROSIL; FLOWLAC; LACTOSE; MACROGOL; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; POLYOX; SENTRY; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; BIOADHESIVE STRENGTH; BULK DENSITY; CHEMICAL PARAMETERS; COMPRESSION; CONTROLLED STUDY; FLOW; GASTRIC RETENTION TIME; HUMAN; HUMAN EXPERIMENT; MALE; MOISTURE; NORMAL HUMAN; PARTICLE SIZE; PH; POWDER; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY; TABLET SURFACE; WETTABILITY;

ADHESIVES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MALE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POWDERS; RADIONUCLIDE IMAGING; TABLETS;

EID: 74949108127     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903037231     Document Type: Article

References (36)

1. Carson JW, Pittenger BH. (1998). Bulk properties of powders. In: Eisen WB, ed. ASM handbook vol. 7-powder metal technologies and applications. Materials Park, OH: ASM International, 287-301.
2. Amidon GE. (1999). Physical test methods for powder flow characterization of pharmaceutical materials: A review of methods. Pharma Forum, 25:8298-8305
3. Dhawan S, Varma M, Sinha VR. (2005). High molecular weight poly(ethylene oxide) based drug delivery systems. Part I: Hydrogels and hydrophilic systems. Pharm Technol, 29:72-80.
4. Needleman IG, Martin GP, Smales FC. (1998). Characterisation of bioadhesives for periodontal and oral mucosal drug delivery. J Clin Periodontol, 25:74-82.
5. Dhawan S, Singla AK. (2004). Composition and method for maintaining blood glucose level. US patent 6,703,045.
6. Dhawan S, Dhawan K, Varma M, Sinha VR. (2005). High molecular weight poly(ethylene oxide). Part II: Applications to drug delivery systems. Pharm Technol, 29:82-96.
7. Dhawan S, Singla AK. (2008). A method of maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition. Indian patent IN212066.
8. Apicella A. (1992). Poly(ethylene oxide) (PEO) and different molecular weight PEO blend monolithic devices for drug release. Congr Int Tecnol Pharm, 4:15-24.
9. Park SJ, Kim KS, Kim SH. (2005). Effect of poly(ethylene oxide) on the release behaviors of poly(epsilon-caprolactone) microcapsules containing erythromycin. Colloids Surf B Biointerfaces, 43:238-244
10. Varma M, Singla AK, Dhawan S. (2004). Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol. Drug Dev Ind Pharm, 30:545-553
11. Talukder R, Fassihi R. (2004). Gastroretentive delivery systems: A mini review. Drug Dev Ind Pharm, 30:1019-1028 (Pubitemid 39577994)
12. Rouge N, Buri P, Doelker E. (1996). Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm, 136:117-139
13. Matharu RS, Sanghavi NM. (1992). Novel drug delivery system for captopril. Drug Dev Ind Pharm, 18:1567-1574
14. Fell JT. (1996). Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract. J Anat, 189:517-519
15. Rocca JG, Omidian H, Shah K. (2003). Progresses in gastroretentive drug delivery systems. Drug Deliv (Oral) Business Briefing, Pharm Tech, 152-156.
16. Hwang SJ, Park H, Park K. (1998). Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst, 15:243-284
17. USP. (2004). United States Pharmacopoeia. Rockwille, MD: The United States Pharmacopoeial Convention, Inc.
18. Kumar V, de la Luz Reus-Medina M, Yang D. (2002). Preparation, characterization, and tabletting properties of a new cellulose- based pharmaceutical aid. Int J Pharm, 235:129-140
19. Carr RL. (1965). Evaluation of flow properties of solids. Chem Eng, 72:163-168
20. Schroder K, Schmid K, Lobenberg R. (2007). Influence of bulk and tapped density on the determination of the thermal conductivity of powders and blends. AAPS PharmSciTech, 8:E78.
21. Shah RB, Tawakkul MA, Khan MA. (2008). Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech, 9:250-258 Epub 2008 Feb 2015.
22. Chrzanowski F. (2008). Preformulation considerations for controlled release dosage forms. Part I. Selecting candidates. AAPS PharmSciTech, 9:635-638
23. Talukdar MM, Kinget R. (1995). Swelling and drug release behaviour of xanthum gum matrix tablets. Int J Pharm, 120:63-72.
24. Lachman L, Lieberman HA, Kanig JL. (1991). The theory and practice of industrial pharmacy. 3rd ed. Bombay: Varghese Publishing House, Hind Rajasthan Building, Dadar.
25. Young PM, Edge S, Staniforth JN, Steele DF, Traini D, Price R. (2007). Effect of moisture on the compressibility and compactibility of sodium starch glycolate. Pharm Dev Technol, 12:217-222
26. Bravo-Osuna I, Ferrero C, Jimenez-Castellanos MR. (2007). Influence of moisture content on the mechanical properties of methyl methacrylate-starch copolymers. Eur J Pharm Biopharm, 66:63-72.
27. Kaerger JS, Edge S, Price R. (2004). Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. Eur J Pharm Sci, 22:173-179
28. Picker-Freyer KM, Durig T. (2007). Physical mechanical and tablet formation properties of hydroxypropylcellulose: In pure form and in mixtures. AAPS PharmSciTech, 8:E92.
29. Uribarri E, Laguna A, Sierra R, Ricardo Y. (2002). Physicomechanical characterization of policosanol, a novel hypocholesterolemic drug. Drug Dev Ind Pharm, 28:89-93.
30. Patel VM, Prajapati BG, Patel HV, Patel KM. (2007). Mucoadhesive bilayer tablets of propranolol hydrochloride. AAPS Pharm- SciTech, 8:E77.
31. Patel VM, Prajapati BG, Patel MM. (2007). Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech, 8:22.
32. Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2003). Mucoadhesive buccal patches of miconazole nitrate: In vitro/in vivo performance and effect of ageing. Int J Pharm, 264:1-14.
33. Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing watersoluble drugs. Drug Dev Ind Pharm, 30:995-1004.
34. Adhikary A, Vavia PR. (2008). Bioadhesive ranitidine hydrochloride for gastroretention with controlled microenvironmental pH. Drug Dev Ind Pharm, 34:860-869
35. Singh B, Pahuja S, Kapil R, Ahuja N. (2009). Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics. Acta Pharm, 59:1-13.
36. Singh B, Chakkal SK, Ahuja N. (2006). Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech, 7:E1-10.